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Abstract
The separation of sister chromatids at anaphase, which is regulated by an
E3 ubiquitin ligase called the anaphase-promoting complex/cyclosome
(APC/C), is arguably the most important irrevocable event during the cell
cycle. The APC/C and cyclin-dependent kinase 1 (Cdk1) are just two of the
many significant cell cycle regulators and exert control through
ubiquitylation and phosphorylation, respectively. The temporal and spatial
regulation of the APC/C is achieved by multiple mechanisms, including
phosphorylation, interaction with the structurally related co-activators
Cdc20 and Cdh1, loading of distinct E2 ubiquitin-conjugating enzymes,
binding with inhibitors and differential affinities for various substrates. Since
the discovery of APC/C 25 years ago, intensive studies have uncovered
many aspects of APC/C regulation, but we are still far from a full
understanding of this important cellular machinery. Recent high-resolution
cryogenic electron microscopy analysis and reconstitution of the APC/C
have greatly advanced our understanding of molecular mechanisms
underpinning the enzymatic properties of APC/C. In this review, we will
examine the historical background and current understanding of APC/C
regulation.
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Introduction
The ubiquitin pathway is an ATP-dependent tagging system 
which regulates a plethora of events in eukaryotic cells by con-
trolling protein stability, localisation, assembly or activity of the 
target substrate1–3. Together with phosphorylation, the ubiquitin-
tagging “ubiquitylation” is the most frequently observed post- 
translational modification in vivo. Thus, it is no exaggeration 
to say that at least some key proteins in many seminal pathways 
and signalling events observed in our body are regulated by 
ubiquitylation. In this process, ubiquitin, a highly conserved 
76-residue protein, is initially linked to a ubiquitin-activating 
enzyme (E1) in a reaction that uses ATP. The activated 
ubiquitin is then transferred to a small ubiquitin-conjugating 
enzyme (E2), forming a thioester-linked E2-ubiquitin inter-
mediate (E2~Ub). E2 acts either alone or in conjunction with 
an E3 ubiquitin ligase to conjugate ubiquitin, most commonly, 
onto the ε-amino group of lysine residues in substrate proteins, 
forming an isopeptide bond1,2,4. These seemingly simple 
sequential actions of three enzymes (E1-E2-E3) are tightly con-
trolled to achieve accurate and appropriately timed ubiquitylation/ 
proteolysis. More than 3% of genes in eukaryotic genomes are 
involved in the ubiquitin system, using multiple layers of regula-
tion, to maintain homeostasis throughout the cell and organism.
The anaphase-promoting complex/cyclosome (APC/C) was 
discovered as an unusually large E3 ubiquitin ligase of cyclin B 
by biochemical fractionation of Xenopus egg and clam oocyte 
extracts5,6. Around the same time, genetic screening using yeast 
mutants defective in cyclin B proteolysis during anaphase and 
G1 identified genes such as APC6/CDC16 and APC8/CDC237. 
Purification of APC/C from Xenopus egg extract demonstrated 
the presence of homologues of budding yeast Apc6/Cdc16 and 
Apc3/Cdc27, which were required for cyclin destruction and 
anaphase progression in fungi and mammalian cells8–11. Hence, 
the idea that the APC/C ubiquitin system5–7, essential cellular 
machinery, controls not only cyclin destruction but also the ini-
tiation of anaphase in all eukaryotes arose and turned out to 
be true. Shortly thereafter, securin/Cut2/Pds1 was identified as 
the first non-cyclin APC/C substrate required for sister chromatid 
separation12,13. This opened up a new chapter of proteolysis- 
driven cell cycle control in the mid-1990s, and to date a 
considerable number of APC/C substrates have been identified.
APC/C activity is under tight control to ensure that APC/C sub-
strates are ubiquitylated and degraded at the right time and 
the right place during the cell cycle14–18. What are the underly-
ing mechanisms? How can we control it if it is mis-regulated? 
Although we have known for a quarter of a century that the 
APC/C is an E3 ubiquitin ligase, the enormity (1.2 MDa) and 
complexity (14 subunits) of the enzyme have hindered the 
reconstitution of apo-APC/C complex and subsequent detailed 
analysis until recently19. Now, high-resolution structural stud-
ies using reconstituted APC/C and multidisciplinary approaches 
have advanced our understanding of the APC/C. Here, we give an 
overview of APC/C regulation to date and highlight emerg-
ing themes. Readers interested in aspects of APC/C structural 
regulation that are beyond the scope of this review are pointed 
to recent comprehensive review articles20,21.
The APC/C is a multi-subunit cullin-RING E3 
ubiquitin ligase
The APC/C belongs to the RING finger family of E3 ubiqui-
tin ligases22–26. Unlike the HECT E3s that form E3~Ub interme-
diates during ubiquitin transfer, the RING E3s lack active sites 
and do not participate chemically in ubiquitin transfer. Instead, 
the RING E3 ubiquitin ligase functions as a scaffold that 
brings together an E2~Ub and a substrate (Figure 1A), thereby 
catalysing ubiquitin transfer from the E2 to the substrate. The 
E3s typically behave as two-substrate enzymes in which the 
E2~Ub and substrate are the two reactants whose binding affini-
ties both influence the reaction rate. In addition, the APC/C 
exploits one more component, a co-activator such as Cdc20 and 
Cdh1, as a substrate recruitment adaptor and APC/C activa-
tor (Figure 1B). Thus, APC/C activation can be regulated by 
multiple mechanisms, including the interactions or spatiotempo-
ral regulations among these four elements together with ubiquitin 
molecules, all of which can be subject to post-translational modi-
fications such as phosphorylation and inhibitor/pseudo-substrate 
binding. It is also likely that individual substrate–co-activator 
binding strength or mode or both regulate the formation of 
APC/C-E2~Ub and the substrate ubiquitylation. Adding yet 
another level of complexity, the APC/C (E3) consists of multi-
ple subunits and exploits two E2 enzymes (for example, Ube2C 
and Ube2S) to achieve programmed ubiquitylation (Figure 1C).
Structure and mechanisms of the APC/C
Early cryogenic electron microscopy (cryo-EM) studies of 
yeast and vertebrate APC/C revealed that APC/C has a triangu-
lar or asymmetric heart-shape (V-shape) conformation27–30, which 
has been refined with the latest high-resolution cryo-EM31–33 
(Figure 2A). The APC/C complex consists of 14 mostly highly 
conserved subunits (Apc1–8, 10–13, 15 and 16) in metazoans 
(13 subunits in yeast) together with a structurally related inter-
changeable Cdc20/Fizzy family of co-activators such as Cdc20 
and Cdh1, generating an “active” macromolecular machine 
exceeding 1.2 MDa (Figure 2B). It should be noted that 
co-activators are not stoichiometric components of the APC/C, 
but the association of co-activators with the APC/C is essential 
for the APC/C to function. The most prevalent structural motif 
is a 34–amino acid tetratricopeptide repeat (TPR), which is 
present in five subunits (Apc3, Apc5, Apc6, Apc7 and Apc8), 
highlighting their role in coordinating the higher-order assembly 
and protein recognition/binding. As an organised structure, the 
APC/C complex can be divided into three sub-complex struc-
tures: the catalytic sub-complex (catalytic module), the substrate 
recognition sub-complex (TPR lobe) and the scaffolding sub-
complex (platform) (Figure 2C). The catalytic module consists of 
Apc11, the RING domain subunit and Apc2, the cullin subunit. 
The minimal module of Apc11-Apc2 (heterodimer) can cata-
lyse ubiquitin transfer but with poor substrate specificity24–26. The 
substrate recognition TPR lobe comprises four TPR subu-
nits (Apc7, Apc3, Apc6 and Apc8), each of which forms a 
V-shaped homodimer via N-terminal domains, which are packed 
in a parallel fashion resulting in the formation of a left-handed 
superhelical structure. Two copies of Apc12/Cdc26/Hcn1, which 
had been shown to genetically interact with Apc6/Cdc16/Cut934,35, 
stabilise Apc6A and Apc6B as molecular chaperones. Apc13 
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Figure 1. Schematic diagrams of RING E3 ubiquitin ligases. RING-type E3 ligases serve as scaffolds to bring together the E2~Ub conjugate 
and the substrate. E3s play a role in stimulating Ub transfer to the substrate from E2~Ub conjugate. E2-binding RING domain is coloured in 
light blue. (A) Monomeric RING E3 ubiquitin ligases (for example, c-Cbl). (B) A simplified cartoon view of APC/C RING E3 ubiquitin ligase 
with a co-activator such as Cdc20 and Cdh1. (C) The APC/C is a multi-subunit cullin-RING E3 ubiquitin ligase that uses two E2s. APC/C, 
anaphase-promoting complex/cyclosome.
Figure 2. APC/C structure and overall organisation. (A) APC/C structure. The image was generated by using the Protein Data Bank file 
(4UI9). The indicated numbers represent APC/C subunits. (B) Schematic view of the APC/C structure based on (A). Left: APCCdc20; right: 
APC/CCdh1. Cdc20 activates the APC/C in metaphase and anaphase to degrade substrates such as cyclin B and securin and then Cdh1 
takes over to degrade APC/C substrates in late anaphase and G1. (C) The APC/C complex can be divided into three modules: the catalytic 
module (Apc2-Apc11) that interacts with E2s, the substrate recognition TPR lobe and the scaffolding platform (Apc1-Apc4-Apc5). During 
the ubiquitylation catalysis, both substrate and E2s are positioned in or near the APC/C central cavity. APC/C, anaphase-promoting complex/
cyclosome; TPR, tetratricopeptide repeat.
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and Apc16 also help stabilise TPR subunit interaction and the 
assembly of the complex. Importantly, the substrate recognition 
of the TPR lobe is through the WD40 domain of Cdc20/Cdh1 
and Apc1036,37, both of which interact with the C-terminal TPR 
grooves of Apc3 through their C-terminal isoleucine-arginine (IR) 
tails. Finally, the scaffolding sub-complex of the APC/C com-
prises the platform subunits Apc4 and Apc5 (heterodimer) and the 
largest subunit Apc1, which bridges the catalytic module Apc11-
Apc2 and the TPR lobe in catalytically favourable conforma-
tions (Figure 2C). Since Apc4 and Apc5 had been shown to 
genetically interact with each other, the dimer formation had been 
suspected and the detailed interaction has been solved by 
high-resolution EM studies31,32. Apc1 has a WD40 beta-propeller 
domain containing several disordered loop domains at the 
N-terminus, one of which mediates phosphorylation-dependent 
APC/C control (Figure 3). It also contains a central PC 
(proteasome-cyclosome) repeat domain, which interacts with 
Apc10, although the detailed regulation remains elusive. In the 
overall topology, the surprising beauty of the whole is that vital 
ubiquitylation elements such as a catalytic E2-binding mod-
ule (Apc11-Apc2) and substrate-binding module (Cdc20/Cdh1 
and Apc10) are all positioned facing a central cavity “catalytic 
centre” on this enormous multi-subunit complex31,32 (Figure 2).
The APC/C employs two E2s and assembles poly-
ubiquitin chains
Ubiquitin has seven lysine residues (K6, K11, K27, K29, K33, 
K48 and K63), so eight structurally distinct types of poly-ubiq-
uitin chain linkage can be formed, together with the N-terminal 
methionine (M1; a head-to-tail linear linkage). The anaphase-
promoting complex (APC/C) can assemble K11-linked and 
K48-linked ubiquitin chains on substrates38–45. In order to build 
K11-linked ubiquitin chains, the metazoan APC/C uses two 
families of E2 enzymes: a “chain-initiating” E2 such as Ube2C/
UbcH10 and Ube2D/UbcH5 and an “elongating” E2 such as 
Ube2S38–40,46,47. The APC/C facilitates these “team tagging” 
Figure 3. Phosphorylation-dependent activation of the APC/C for APC/CCdc20. Interphase APC/C is inactive without the recruitment of 
Cdc20, which is presented from a front view and a back view of the APC/C. The disordered loop domain of Apc1 (Apc1-loop300), which is 
located in the N-terminal WD40 domain, blocks Cdc20-NTD access to the APC/C, in particular the C-box–binding sites on Apc8B. Yellow dotted 
circle highlights the C-box–binding site. In mitosis, Cdk1-cyclinB-Cks phosphorylates the disordered loop domain of Apc3 (Apc3loop), which 
allows Cks-bound Cdk1-cyclin B loading to Apc3loop. Cdk1-cyclinB-Cks then stimulates phosphorylation of Apc1-loop300 as an intramolecular 
phosphorylation relay. Upon phosphorylation, inhibitory domain Apc1-loop300 is dislocated from the C-box–binding site, allowing Cdc20 
association, the C-box-dependent activation and subsequent ubiquitylation catalysis (“cartoon view of the APC/C”). The isoleucine-arginine 
(IR) tail of Cdc20 binds to Apc3 and the C-box interacts with Apc8B for activation of the APC/C. Both IR tail binding and C-box binding ensure 
stable binding of co-activator (Cdc20) to the APC/C. The WD40 domain of co-activator is responsible for substrate degron recognition. The 
RING subunit Apc11 is coloured in light blue. APC/C, anaphase-promoting complex/cyclosome.
Page 5 of 15
F1000Research 2019, 8(F1000 Faculty Rev):725 Last updated: 23 MAY 2019
reactions by placing Ube2C and Ube2S at dedicated locations 
within the APC/C complex31,32. Ube2C binds the RING subunit 
Apc11 and Apc2 and transfers the first ubiquitin onto substrates 
(that is, multiple monoubiquitylation), whereas Ube2S binds 
non-RING subunits Apc2 and Apc4 through its C-terminal LRRL 
tail and elongates the K11-linked ubiquitin chains onto sub-
strate-attached ubiquitin. RING subunit Apc11 involvement with 
Ube2C binding is as expected, but Apc2 plays an important role in 
interacting with both Ube2C and Ube2S through the winged- 
helix B (WHB) domain and the N-terminal domain of Apc2, 
respectively32,48,49. It has also been reported that the back surface 
of Apc11 has an additional role in tracking and presenting the 
acceptor ubiquitin of the growing ubiquitin chain onto Ube2S, 
thereby ensuring K11-linked ubiquitin chain formation31,50,51. 
Yet detailed mechanisms and the control of Ube2C and Ube2S 
loading and activity are mostly unknown. Interestingly, it has 
recently been observed that Ube2S does not simply extend 
a ubiquitin chain but creates mixed or branched K11/K48-linked 
ubiquitin chains, which act as better degradation signals for 
the proteasomal receptors than homotypic K11- or K48-linked 
ubiquitin chains41–43. How proteasomal ubiquitin-receptor proteins 
by themselves or in combination with UBL-UBA shuttle factors 
(for example, Rad23 and Dsk2) efficiently recognise branched 
ubiquitin chain configuration is not known. It is possible that 
mixed ubiquitin chains are more resistant to de-ubiquitylating 
enzymes (DUBs). In the past, E2 enzymes were considered 
just intermediates of the ubiquitin pathway, but more “active” 
roles have recently been discovered52,53. Not only “team tagging” 
but also new layers of E2 regulation might emerge in APC/C 
regulation in the future.
Multifaceted regulation of the APC/C is mediated 
primarily by co-activators
Cdc20/Fizzy, a co-activator of the APC/C, was originally dis-
covered as fly and yeast mitotic mutants that failed to initiate 
the onset of anaphase. Cdh1 was subsequently identified as a 
G1 co-activator54–58. Cdc20 or Cdh1 is around 55 kDa and con-
stitutes less than 5% of the total mass of the APC/C complex 
(1.2 MDa), but the size does not matter. A co-activator has an 
absolute requirement for APC/C-dependent ubiquitylation. 
Initially, the WD40 domain-mediated “substrate capture” role 
was revealed59–61 and later the “activation role” through the C-box 
(a conserved motif in the Cdc20/Fizzy family of proteins) at the 
N-terminal domain was uncovered62,63. From biochemical and 
EM studies, the activation mechanism is thought to be through 
conformational changes within the APC/C complex; the C-box 
and Apc8B interaction shifts the catalytic module (Apc11-Apc2) 
upward and positions it in a catalytically favourable conforma-
tion, allowing E2~Ub loading32,33,63. Here, three key facets of 
APC/C regulation via co-activators (that is, substrate recognition, 
phospho-regulation and inhibition) will be discussed briefly.
Co-activator–substrate affinity might determine the 
rate of ubiquitylation
Substrate recognition, which is a prerequisite for ubiquityla-
tion catalysis, is one of the most important roles performed by 
co-activators, together with Apc1036,37,59–61,64,65. The APC/C sub-
strates have a destruction motif or degron module sequence to 
be recognised by the WD40 domain of co-activators. The best- 
defined destruction motifs are the destruction box (D-box) with 
a consensus of RxxLxxxxN66 and the KEN-box, named after 
its consensus sequence, KENxxxN67, although the amino acid 
residues outside of the core RxxL and KEN are far more vari-
able. The ABBA motif (Fx[ILV][FY]x[DE]) conserved in cyc-
lin A, BubR1, Bub1 and Acm1 is a more recently characterised 
APC/C degron68–70. Also, there are less characterised degrons such 
as CRY-box or O-box and presumably as-yet-unidentified cryp-
tic D-box or KEN-box exist. Each degron binds to a designated 
surface of the WD40 domain; for example, the D-box degron 
binds to a pocket situated between blades 1 and 7, whereas 
the KEN-box binds at the centre of the top surface of the wheel-
like WD40 repeat domain70–72. Mutations, in the degron module 
on a substrate or the corresponding channel surface in the WD40 
domain, that block substrate–co-activator interaction, render 
that substrate unavailable for ubiquitylation. The D-box– and the 
KEN-box–binding pockets/surfaces are evolutionally well con-
served despite slight variations between Cdc20 and Cdh1 and 
those among species. Yet this may be a matchmaker mechanism, 
generating variable and dynamic affinities, by which degron 
module sequences on candidate substrates can be scanned and 
interrogated. As a consequence, if recognised as a genuine sub-
strate, the degron specifically binds the WD40 surface with 
the correct affinity programmed by its degron sequence, which 
may determine processive or poor ubiquitylation of the substrate. 
The strength of interaction is likely to be regulated by environ-
mental cues as it has been reported that the phosphorylation state 
around the degron region can influence the ubiquitylation of 
substrates (for example, Cdc6)73. Too strong or too weak inter-
action is probably not good for ubiquitylation. However, some 
APC/C inhibitors such as Mes1 or Acm1 seem to use such exces-
sive affinity on purpose to inhibit the APC/C74–76. It should be 
noted that Cdh1 has a broader substrate specificity than Cdc20. 
It is likely that traits on the WD40 domain are responsible for 
such specificity, although the underlying mechanism remains 
obscure.
Phosphorylation regulates APC/CCdc20 and APC/CCdh1
The APC/C is “cell cycle–regulated”, which was very clearly 
described in original discovery papers5,6. Cdc20 binds and 
activates mitotically phosphorylated APC/C77–82. However, because 
many sites on the APC/C subunits are phosphorylated by cyc-
lin-dependent kinase 1 (Cdk1)83,84, the sites of phosphorylation 
and their impacts have not been defined. Recently, the expres-
sion of recombinant APC/C and extensive site-directed mutagen-
esis of different subunits has uncovered the mechanism underly-
ing the activation of the APC/C by Cdk1 phosphorylation85,86 
and this has been confirmed by high-resolution EM studies87 
(Figure 3). The model also supports the theory that Cdk1- 
dependent APC/C phosphorylation is the trigger for anaphase 
onset. In addition, the study highlights the importance of disor-
dered loop domains of the APC/C subunits for dynamic regulation. 
Although Apc3 and Apc1 are clearly key subunits for phos-
pho-regulation, other sites are also phosphorylated in vitro and 
in vivo. The roles of such phosphorylation remain elusive. 
Furthermore, how phosphorylation of the APC/C is regulated by 
phosphatases or how “teamwork” phosphorylation with other 
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mitotic kinases (for example, polo-like kinase) is achieved for 
APC/C regulation requires elucidation.
Cdk1-dependent phosphorylation of Cdh1 is inhibitory, as 
shown in the late 1990s88,89, explaining the observation that 
Cdh1 action is repressed in mitosis and Cdc20 is the predomi-
nant co-activator. However, like Cdh1 phosphorylation, Cdk1- 
dependent phosphorylation of Cdc20 was shown to block an 
APC/C activation role through the C-box63. In mitosis, protein 
phosphatases such as PP2A dephosphorylate and activate 
Cdc2063. Yet the situation is slightly more complicated as in mito-
sis the APC/C needs to be phosphorylated (Figure 3) whereas 
Cdc20 needs to be dephosphorylated for the C-box–dependent 
activation of the APC/C. How can this conundrum be resolved? 
One mechanism seems to involve PP2A substrate specificity. 
PP2A complexes have an inherent preference for phospho-
threonine over phosphoserine90–93. Notably, the key Cdk1 sites 
around the C-box of Cdc20 are threonine63 whereas Cdk1- 
phosphorylation sites in Apc1 loop300 are exclusively serine85–87. 
Thus, Cdc20 can be more efficiently dephosphorylated than 
the APC/C, allowing APC/CCdc20 complex formation during the 
correct window. It is unknown exactly how and which subfamilies 
of PP2A are involved in Cdc20 and APC/C dephosphorylation 
and whether other phosphatases such as PP1 are involved and, 
if so, how they are regulated. It should be noted that key Cdk1 
sites of Cdh1 are serine; thus, Cdh1 dephosphorylation and 
subsequent Cdh1-dependent APC/C activation occur only 
after Cdk1 inactivation and subsequent activation of Cdk- 
counteracting phosphatases89,94–97, which initiate mitotic exit. Cdh1 
phosphorylation is also involved in its subcellular localisation, 
contributing to the spatiotemporal regulation of the APC/C98–100.
APC/C activity can be inhibited at multiple levels
Inhibitors are often very useful to explore the underlying mecha-
nisms or processes of how a regulatory system works as criti-
cal processes are often targeted (Figure 4). Classic APC/C 
inhibition may involve overproduction of the D-box (high dose 
of the D-box) fragments, which can overwhelm the substrate 
recognition of Cdc20 (Figure 4A) and arrest cells at metaphase 
(by inhibiting APC/C)101–103. This finding suggested that proteins 
other than cyclin must be degraded to initiate anaphase, leading 
to the discovery of Cut2/securin12,13. Through the degron–WD40 
interactions, Mes1 in Schizosaccharomyces pombe acts as 
a pseudo-substrate inhibitor for Fzr1/Mfr1 but works as a 
competitive substrate for Slp1/Cdc20, by which Mes1 con-
trols the activity of the APC/C required for the meiosis I/II 
transition76,104,105. Similarly, the degron motifs of Acm1 in 
Saccharomyces cerevisiae are recognised in different ways 
by the WD40 domain of Cdh1 and Cdc2070,74,75,106,107, so that 
Acm1 becomes an inhibitor of Cdh1 but not Cdc20.
Through a chemical genetic screen in Xenopus egg extracts, 
tosyl-L-arginine methyl ester (TAME), a small-molecule APC/C 
inhibitor, has been isolated108. TAME structurally resembles 
the IR tail of co-activators and thus blocks Cdc20/Cdh1 load-
ing onto the APC/C via the IR tail109 (Figure 4B). As the 
C-box–binding site on Apc8 is structurally equivalent to the IR 
tail–binding site on Apc332, TAME potentially affects the C-box 
function as well as the IR tail87. TAME is more specific to 
Cdc20 than Cdh1. This seems to be due in part to the fact that 
Cdh1 has more contact with the APC/C, achieving higher 
affinity, but the detailed mechanism remains elusive. Another 
inhibitor molecule, known as Apcin, which was isolated from 
Figure 4. APC/C inhibitors target the APC/C at multiple levels. (A) Overexpression or high dose of the destruction box (D-box) fragment 
(+op-D-box) competes with substrates to bind to the D-box–binding pocket on the WD40 domain (competitive inhibition). A small-molecule 
Apcin binds the D-box–binding pocket on the side face of the WD40 domain (+Apcin). (B) A small-molecule tosyl-l-arginine methyl ester 
(TAME), which resembles the isoleucine-arginine (IR) tail of Cdc20 and Cdh1, binds APC3 to interfere with the IR tail–binding site (+TAME). EM 
study suggests that TAME might compete with Cdc20 to bind at the IR tail and the C-box–binding sites. (C) Emi1 inhibits the APC/C at multiple 
levels (+Emi1). The D-box (weak) binds the WD40 domain of Cdc20/Cdh1, a zinc-binding region (ZBR) interferes with Ubc2C-dependent 
APC/C activity and the C-terminal LRRL tail interferes with Ube2S binding to the APC/C. The LRRL tail sequence of Emi1 is identical to the 
LRRL motif of Ube2S. In vivo target of Emi1 is Cdh1. (D) The main effector of the spindle assembly checkpoint (SAC) is the mitotic checkpoint 
complex (MCC), which inhibits the APC/C at multiple levels. In vivo target of MCC is Cdc20. MCC binds both the D-box–binding pocket 
and the KEN-box–binding surface of the WD40 domain and blocks WD40-mediated substrate binding. MCC also blocks Ube2C-dependent 
APC/C activity at the closed MCC configuration; however, Ube2S-dependent APC/C activity is not inhibited by MCC. Schematic diagrams are 
based on the cartoon view of the APC/C in Figure 3 (bottom left). APC/C, anaphase-promoting complex/cyclosome.
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the same chemical screenings, binds to the D-box–binding site 
of the WD40 domain of Cdc20 (Figure 4A)110. This finding has 
created a great opportunity for synergistic inhibition using both 
TAME and Apcin, which has proven to be more effective than 
either alone110.
Early mitotic inhibitor (Emi)1 is a metazoan APC/C inhibitor111 
which is a vertebrate homologue of Rca1 (regulator of cyc-
lin A). In Drosophila, Rca1 inhibits APC/CCdh1 and stabilises 
cyclin A in S phase112,113. Emi1 has been shown to inhibit both 
APC/CCdc20 and APC/CCdh1 activity in vitro111,114 but its main pur-
pose is thought to be inhibition of APC/CCdh1 during S and G2115,116. 
Emi1 has a C-terminal inhibitory domain composed of structural 
components such as the D-box, Linker, ZBR and RL tail 
(Emi1DLZT)117,118. The Emi1 C-terminal domain was previously 
proposed to be a pseudo-substrate inhibitor119, but cryo-EM 
and quantitative biochemical analysis have revealed a more 
sophisticated inhibition mechanism; Emi1 apparently uses 
every structural property within the Emi1DLZT domain and blocks 
APC/C ubiquitylation processes, including Ube2S-dependent 
ubiquitin chain elongation32,117,118 (Figure 4C). It should be 
noted that Emi1 destruction is regulated by another E3 ubiquitin 
ligase, SCFβTRCP, through the degron on its N-terminal domain 
upon phosphorylation120–122. Also, Emi1 activity is negatively 
regulated by Cdk1 phosphorylation123. Because of the high 
potency of Emi1, it is controlled by multiple layers of regula-
tion, including transcriptional and translational changes124,125.
Emi2 (also called Erp1), a maternal paralogue of Emi1, inhib-
its the APC/C in a similar manner to Emi1, so that verte-
brate eggs awaiting fertilisation are arrested at metaphase of 
meiosis II126,127.
Finally, the spindle assembly checkpoint (SAC) monitors unat-
tached or tensionless kinetochores and delays the onset of 
anaphase until all the kinetochores are attached to form a proper 
bipolar spindle structure128–130. The mitotic checkpoint com-
plex (MCC) consisting of Mad2, BubR1, Bub3 and Cdc20 is 
a potent APC/C inhibitor (Figure 4D). MCC was recently shown 
to inhibit a second Cdc20APC/C that has already bound and acti-
vated the APC/C, highlighting that MCC can indeed act as a direct 
APC/C inhibitor, rather than sequestering Cdc20131. High- 
resolution cryo-EM studies of APC/C-MCC complex reveal that 
BubR1 binding mislocates Cdc20APC/C and blocks substrate rec-
ognition48,49. The MCC docks into the APC/C central cavity and 
also interferes with Ube2C recruitment, inhibiting most of the 
substrate ubiquitylation. Intriguingly, a subset of substrates such 
as Nek2A or cyclin A, which can bind the APC/C independently 
of the WD40 of co-activators, can be degraded even when SAC 
is active132–134. It might be that Nek2A binds to a TPR subunit 
that MCC does not interfere with (for example, Apc6B or Apc7) 
by which Nek2A is ubiquitylated and degraded as long as the 
proper interaction between the C-box and Apc8B is ensured. 
Once all kinetochores become stably attached to the spindle, the 
SAC has to be silenced to allow anaphase onset. p31comet is an SAC 
antagonist135 and is involved in SAC silencing in multiple ways, 
such as blocking Mad2 activation by binding to C-Mad2136,137 
and assisting MCC disassembly together with the AAA+ ATPase 
TRIP13138–143. Cdc20 auto-ubiquitylation is also involved in 
MCC disassembly144–149. Yet it appears that several pathways 
regulate SAC activation as well as SAC silencing in vivo150–155, 
so further work is necessary to elucidate the detailed mecha-
nisms. Regulation of the SAC pathway has been reviewed by 
others20,21,156–158.
Future perspectives
Recent progress on the resolution of cryo-EM is amazing, 
entailing near atomic resolution now and inevitable atomic 
resolution in the future. The MultiBac-based reconstitution pipe-
line of the whole APC/C complex allows construction of any 
mutation(s) in any subunit(s) at will, which provides an unprec-
edented opportunity to interrogate detailed dynamic regulation in 
physiological conditions such as Xenopus egg extracts together 
with the latest structural technologies, in combination with cell 
biological, genetic, biochemical, bioinformatics or mathemati-
cal modelling approaches. By combining genome editing and 
RNA interference, mammalian cell biology approaches will also 
provide unprecedented details of APC/C regulation. Yet we still 
face a number of outstanding questions. Why is the APC/C so 
large and why are so many subunits required for APC/C activ-
ity? Has evolution contributed to the enormous size and the 
complexity of the subunits? Are there any as-yet-unidentified 
subunit or sub-complex functions besides ubiquitylation? Is the 
APC/C complex disassembled partly or even fully and 
how is it regulated? We know that cellular subunit expression lev-
els vary depending on subunit, so it may be that some subunits 
behave as a core regulating the assembly. Another key issue 
is the influence of subcellular localisation on APC/C function 
in vivo. Local concentration of not only the APC/C but also 
co-activators, E2s, substrates and inhibitors would all 
affect APC/C activity. Furthermore, our knowledge of ubiq-
uitin dynamics regulating and maintaining the relationship 
between the APC/C and the action of DUBs is still very limited, 
although very recently Cezanne/OTUD7B was shown to be 
a cell cycle–regulated DUB antagonising APC/C activity159. 
Moreover, increasing evidence suggests that dysregulation of 
Cdc20 or Cdh1 is involved in disease conditions and progres-
sion as in cancer. Deeper knowledge of the APC/C ubiquitin 
system and the mechanisms of distinct co-activator working 
will ultimately contribute to not only a better understanding 
of the cell cycle but also the possible development of therapies 
or tools to control or monitor dysregulated APC/C.
Closing remarks
The discovery of MPF as a complex of cyclin B and 
Cdk1/Cdc2 in the late 1980s heralded the first wave of under-
standing of the cell cycle in modern times. Many scientists fol-
lowing their own interests and curiosity had conducted studies 
in a number of model organisms such as frog, starfish, clam, 
sea urchin, yeast (budding and fission), fly and human cell cul-
ture systems160–173. Collaborative and comparative analysis of 
all this research unveiled the MPF story. In September 1988, at 
a key moment in the beginning of cell cycle research, the first 
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CNRS Cell Cycle meeting in Roscoff (France) was organised, 
highlighting the efficacy of collaboration and a multidiscipli-
nary approach to solve important questions in science. With con-
tinued passion and curiosity, hard work and luck, much can be 
achieved, not only to further our understanding of the cell 
cycle but to pave the way for exciting new advances in the field 
of medicine.
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